Dirk Johannes Van Den Boom

This inventor holds 33 USPTO granted patents and 21 published patent applications, plus 9 CIPO patents and 13 EPO patents, primarily in Nucleic Acid Diagnostics. Top assignees: Sequenom, Inc., Agena Bioscience, Inc., Agena Biosciences, Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dirk Johannes Van Den Boom. Retrieved from https://idiyas.com/inventor/dirk-johannes-van-den-boom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 33 (Patent Applications = 21)

% Patents Active = 57.6

CIPO Patents = 9 (Patent Applications = 3)

EPO Patents = 13 (Patent Applications = 12)

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 298(Granted Patents)

Location History:

La Jolla, CA (US) (2007 - 2023)
Encinitas, CA (US) (2015 - 2024)

Company Filing History:

Agena Bioscience, Inc.

patents

1 out of 2

Agena Biosciences, Inc.

patents

4. 1 out of 1

Juno Diagnostics, Inc.

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Multiplex Nucleic Acid Identification

Non-Invasive Assessment

Prenatal Testing

Capillary Blood Collection

Polymerase Chain Reactions

Liquid Biopsy

Mass Spectrometry

Genetic Variation Analysis

Polymorphic Genetic Markers

Methylation-Specific Amplification

Sequence Variation Detection

Phenotype Identification

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630865 - PRODUCTS AND PROCESSES FOR MULTIPLEX NUCLEIC ACID IDENTIFICATION (2026-05-19),

2. 12534758 - Methods and processes for non-invasive assessment of genetic variations (2026-01-27),

3. 12462935 - Deep learning-based methods, devices, and systems for prenatal testing (2025-11-04),

4. 11957465 - Accelerated ergonomic collection of capillary blood (2024-04-16),

5. 11827928 - Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions (2023-11-28),

6. 11783911 - Methods and processes for non-invasive assessment of genetic variations (2023-10-10),

7. 11697849 - Methods for non-invasive assessment of fetal genetic variations that factor experimental conditions (2023-07-11),

8. 11667958 - Products and processes for multiplex nucleic acid identification (2023-06-06),

9. 11525134 - Devices, systems and methods for ultra-low volume liquid biopsy (2022-12-13),

10. 11111530 - Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions (2021-09-07),

11. 11001884 - Methods and processes for non-invasive assessment of genetic variations (2021-05-11),

12. 10604791 - Products and processes for multiplex nucleic acid identification (2020-03-31),

13. 9896724 - Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions (2018-02-20),

14. 9394565 - Allele-specific sequence variation analysis (2016-07-19),

15. 9249456 - Base specific cleavage of methylation-specific amplification products in combination with mass analysis (2016-02-02),

Certainly! Here is the article:

Title: The Innovative World of Dirk Johannes Van Den Boom

Introduction:

Dirk Johannes Van Den Boom, a distinguished inventor based in La Jolla, California, has made significant contributions to the field of genetic variations assessment through his groundbreaking patents. With an impressive portfolio of 34 patents, Dirk has been a trailblazer in developing methods for non-invasive assessment of genetic variations and multiplex nucleic acid identification.

Latest Patents:

Dirk's latest patents showcase his expertise in the realm of genetic analysis. One of his recent inventions includes methods and processes for non-invasive assessment of genetic variations. These methods utilize nucleic acid fragment length information from circulating cell-free nucleic acids, enabling the comparison of fragment counts with varying lengths. Another notable patent involves products and processes for multiplex nucleic acid identification, which allow for the detection of multiple target nucleic acids through innovative techniques such as amplification, capturing, and competition-based detection.

Career Highlights:

Currently employed at Agena Bioscience, Inc., Dirk Van Den Boom continues to drive innovation in the field of genetic analysis. His work at Agena Bioscience, Inc. underscores his commitment to developing cutting-edge solutions for genetic testing and diagnostics, solidifying his reputation as a pioneering figure in the industry.

Collaborations:

In his professional journey, Dirk has collaborated closely with esteemed colleagues such as Mathias Ehrich and Martin Beaulieu. Together, they have worked on various projects aimed at advancing the field of genetic variations assessment and expanding the capabilities of nucleic acid identification techniques.

Conclusion:

In conclusion, Dirk Johannes Van Den Boom stands out as a visionary inventor in the realm of genetic analysis, with a remarkable track record of patents that have transformed the way genetic variations are assessed and identified. His relentless dedication to innovation and collaboration underscores his pivotal role in shaping the future of genetic diagnostics and research.

Profile summary based on public USPTO records.